Experts in stem cell transplantation discuss the approval of ibrutinib and the ongoing REACH3 trial for ruxolitinib in chronic GVHD.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
Ещё видео!
Experts in stem cell transplantation discuss the approval of ibrutinib and the ongoing REACH3 trial for ruxolitinib in chronic GVHD.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]